Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-4 of 4
Keywords: Multidrug resistance
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1997) 20 (4): 310–314.
Published Online: 13 May 2009
.... The expression of the MDR1 gene occurs to various degrees. The multidrug resistance-associated protein is also present in lung cancer cells. Enhanced activities of gluta-thione S-transferases and elevated glutathione levels of tumor cells may contribute to the intrinsic resistance of non-small-cell lung cancer...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1996) 19 (Suppl. 1): 19–22.
Published Online: 12 May 2009
... trigger cellular transformation. In this study, the role of oncogenes was defined in drug-resistant human ovarian carcinoma cells. In both multidrug resistant (actinomycin D) cells and non-multidrug-resistant (cisplatin) cells, Northern analyses demonstrated enhanced gene expression for the following...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1995) 18 (5): 462–467.
Published Online: 11 May 2009
... for in vivo reversal of multidrug resistance. 11 5 2009 © 1995 S. Karger AG, Basel 1995 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1993) 16 (6): 450–453.
Published Online: 08 May 2009
...M. Raderer; D. Depisch; K. Haider; W. Kwasny; M. Djavanmard; W. Scheithauer Background : Because MDRl RNA is frequently encountered in advanced breast cancer, we have initiated a phase I/II study with pirarubicin in combination with the multidrug resistance modifier quinidine. Patients and Methods...